Generation Bio Co. (GBIO)
GBIO Stock Price Chart
Explore Generation Bio Co. interactive price chart. Choose custom timeframes to analyze GBIO price movements and trends.
GBIO Company Profile
Discover essential business fundamentals and corporate details for Generation Bio Co. (GBIO) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
12 Jun 2020
Employees
115.00
Website
https://generationbio.comCEO
Cameron Geoffrey McDonough
Description
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology. The company was formerly known as Torus Therapeutics, Inc. and changed its name to Generation Bio Co. in November 2017. Generation Bio Co. was incorporated in 2016 and is headquartered in Cambridge, Massachusetts.
GBIO Financial Timeline
Browse a chronological timeline of Generation Bio Co. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 5 May 2026
Upcoming earnings on 5 Nov 2025
EPS estimate is -$2.89, while revenue estimate is $660.00K.
Earnings released on 12 Aug 2025
EPS came in at -$3.12 falling short of the estimated -$2.80 by -11.43%, while revenue for the quarter reached $765.00K , missing expectations by -69.29%.
Stock split effective on 22 Jul 2025
Shares were split 1 : 10 , changing the number of shares outstanding and the price per share accordingly.
Earnings released on 7 May 2025
EPS came in at -$2.20 surpassing the estimated -$2.50 by +12.00%, while revenue for the quarter reached $8.72M , beating expectations by +309.43%.
Earnings released on 13 Mar 2025
EPS came in at -$0.32 falling short of the estimated -$0.28 by -14.29%, while revenue for the quarter reached $4.19M , beating expectations by +222.15%.
Earnings released on 6 Nov 2024
EPS came in at -$0.23 surpassing the estimated -$0.28 by +17.86%, while revenue for the quarter reached $7.55M , beating expectations by +158.98%.
Earnings released on 7 Aug 2024
EPS came in at -$0.31 falling short of the estimated -$0.27 by -14.81%, while revenue for the quarter reached $4.09M , beating expectations by +108.72%.
Earnings released on 13 May 2024
EPS came in at -$1.12 falling short of the estimated -$0.36 by -211.11%, while revenue for the quarter reached $4.06M , beating expectations by +111.41%.
Earnings released on 6 Mar 2024
EPS came in at -$0.53 falling short of the estimated -$0.41 by -29.27%, while revenue for the quarter reached $2.88M , beating expectations by +234.65%.
Earnings released on 9 Nov 2023
EPS came in at -$0.43 surpassing the estimated -$0.51 by +15.69%, while revenue for the quarter reached $2.15M , beating expectations by +96.88%.
Earnings released on 2 Aug 2023
EPS came in at -$0.47 surpassing the estimated -$0.49 by +4.08%, while revenue for the quarter reached $880.00K , missing expectations by -75.21%.
Earnings released on 10 May 2023
EPS came in at -$0.53 falling short of the estimated -$0.39 by -35.90%.
Earnings released on 23 Feb 2023
EPS came in at -$0.55 surpassing the estimated -$0.57 by +3.51%.
Earnings released on 3 Nov 2022
EPS came in at -$0.53 surpassing the estimated -$0.67 by +20.90%.
Earnings released on 4 Aug 2022
EPS came in at -$0.66 falling short of the estimated -$0.63 by -4.76%.
Earnings released on 5 May 2022
EPS came in at -$0.61 falling short of the estimated -$0.52 by -17.31%.
Earnings released on 24 Feb 2022
EPS came in at -$0.54 surpassing the estimated -$0.57 by +5.26%.
Earnings released on 10 Nov 2021
EPS came in at -$0.56 falling short of the estimated -$0.55 by -1.82%.
Earnings released on 11 Aug 2021
EPS came in at -$0.55 falling short of the estimated -$0.47 by -17.02%.
Earnings released on 12 May 2021
EPS came in at -$0.46 matching the estimated -$0.46.
Earnings released on 18 Mar 2021
EPS came in at -$0.53 falling short of the estimated -$0.52 by -1.92%.
Earnings released on 10 Nov 2020
EPS came in at -$0.46 falling short of the estimated -$0.45 by -2.22%.
GBIO Stock Performance
Access detailed GBIO performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.